Mazen M. DimachkieMD
Mazen M. Dimachkie, MD, FAAN, FANA, is Professor of Neurology, Director of the Neuromuscular Division at the University of Kansas Medical Center (KUMC) in Kansas City, where he is also Director of the Clinical Neurophysiology and Neuromuscular Medicine Fellowships, Exectuive Vice Chair in the Neurology Department and Associate Director of the Institute for Neurological Discoveries. As the director of KUMC Neuromuscular Research, he manages one of the busiest neuromuscular clinical trials units in North America. He is also Associate Director of the KUMC site participating in the NINDS Network for Excellence in Neuroscience Clinical Trials known as NeuroNEXT.
He received his medical degree from the American University of Beirut in Lebanon before completing 2 years of training in Internal Medicine at Saint Agnes Hospital in Baltimore, Maryland. Dr. Dimachkie then completed a residency in Neurology at UT-Houston from July 1, 1990 to June 30, 1993 and fellowship in electromyography & Neuromuscular Disease from July 1, 1993 to June 30, 1994, both at The University of Texas Health Science Center at Houston (UT-Houston).
He is ABPN board-certified in Neurology, Clinical Neurophysiology, and Neuromuscular Medicine and holds a UCNS certificate in Clinical Neuromuscular Pathology. He was on faculty at the UT-Houton Neurology Department from 1995-2007 before being recruited to lead the prolific neuromuscular Section and now Division at the KUMC. He participates in a wide variety of federally-funded neuromuscular research studies and industry-sponsored studies, nationally and internationally. Dr. Dimachkie is a member of the American Association of Neuromuscular & Electrodiagnostic Medicine, the Peripheral Nerve Society, The Muscle Study Group, and sits on the Medical Scientific Advisory Boards of the Myasthenia Gravis Foundation of America and on The Myositis Association.